Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

November 06, 2024 07:30 ET | Source: Plus Therapeutics Inc.; Spectron RX

Plus Therapeutics and SpectronRx Announce Radiotherapeutic Manufacturing Partnership

Plus Therapeutics and SpectronRx Announce Radiotherapeutic Manufacturing Partnership
November 06, 2024 07:00 ET | Source: Aclaris Therapeutics, Inc.

Aclaris Therapeutics Reports Third Quarter 2024 Financial Results and Provides a Corporate Update

Aclaris Therapeutics Reports Third Quarter 2024 Financial Results and Provides a Corporate Update
November 06, 2024 04:45 ET | Source: Research and Markets

Shock Wave Therapy Device Patent Landscape Report, 2024-2032: Global Shock Wave Therapy Device Market to Reach $3.45 Billion by 2032 as Demand for Portable and Customized Solutions Fuels Patent Surge

Dublin, Nov. 06, 2024 (GLOBE NEWSWIRE) -- The "Shock Wave Therapy Device Patent Landscape Report and Forecast 2024-2032" report has been added to ResearchAndMarkets.com's offering.The global shock...
November 04, 2024 08:00 ET | Source: Phathom Pharmaceuticals

Phathom Pharmaceuticals to Participate in Upcoming Investor Conferences

FLORHAM PARK, N.J., Nov. 04, 2024 (GLOBE NEWSWIRE) -- Phathom Pharmaceuticals, Inc. (Nasdaq: PHAT), a biopharmaceutical company focused on developing and commercializing novel treatments for...
November 01, 2024 05:55 ET | Source: Research and Markets

Thought Leader Engagement in Life Sciences: Refining Strategies and Tactics for Optimal KOL Engagement

Dublin, Nov. 01, 2024 (GLOBE NEWSWIRE) -- The "Thought Leader Utilization: Refining Strategies and Tactics for Optimal KOL Engagement" report has been added to ResearchAndMarkets.com's offering. ...
October 31, 2024 16:05 ET | Source: MannKind

MannKind Corporation to Hold 2024 Third Quarter Financial Results Conference Call on November 7, 2024

Mannkind Corporation to Hold 2024 Third Quarter Financial Results Conference Call on November 7, 2024
October 30, 2024 16:05 ET | Source: Lumos Pharma, Inc.

Lumos Pharma Announces Two Abstracts Accepted for Oral Presentation at the 62ⁿᵈ Annual ESPE Meeting 2024

AUSTIN, Texas, Oct. 30, 2024 (GLOBE NEWSWIRE) -- Lumos Pharma (NASDAQ:LUMO), a clinical stage biopharmaceutical company focused on therapeutics for rare diseases, announced today that updated...
October 29, 2024 07:30 ET | Source: Plus Therapeutics Inc.

Plus Therapeutics Showcases Leptomeningeal Metastases Programs at the 2024 SNO Annual Meeting in Houston, Texas

Plus Therapeutics Showcases Leptomeningeal Metastases Programs at the 2024 SNO Annual Meeting in Houston, Texas
October 29, 2024 02:30 ET | Source: Custom Market Insights

[Latest] Global Hydrolyzed Vegetable Protein Market Size/Share Worth USD 3,556.8 Million by 2033 at a 6.9% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth, Growth Rate, Value)

Austin, TX, USA, Oct. 29, 2024 (GLOBE NEWSWIRE) -- Custom Market Insights has published a new research report titled “Hydrolyzed Vegetable Protein Market Size, Trends and Insights By Source (Pea,...
October 28, 2024 10:00 ET | Source: HOPO Therapeutics, Inc.

HOPO Therapeutics Awarded Up to $226 Million from BARDA for Advanced Development of its Oral Decorporation Agent for Heavy Metal Toxicity

HOPO Therapeutics Awarded Up to $226 Million from BARDA for Advanced Development of its Oral Decorporation Agent for Heavy Metal Toxicity